Leviathan Cannabis Group Inc.
Leviathan aspires to become a leading multi-jurisdictional cannabis enterprise, combining exceptional genetics and product formulations with ground breaking branding and marketing expertise, coupled with a proprietary global distribution platform. The Leviathan portfolio currently comprises Jekyll+Hyde Brand Builders Inc., a marketing services agency specializing in the cannabis sector, and Woodstock Biomed Inc., a late stage applicant under the ACMPR, which is in the process of retrofitting a substantial greenhouse production facility in Pelham, Ontario. Leviathan has also announced its intention to acquire Pulse Rx Inc., a boutique-style pharmacy currently providing core pharmacy services to institutional clients including nursing and retirement homes. Pulse Rx will form an integral component in Leviathan's future retail distribution model for cannabis products.
Leviathan Cannabis Group Inc. (EPIC)
Le 11 avril/April 2018
Morgan Resources Corp. has announced a name change to Leviathan Cannabis Group Inc.
Shares will begin trading under the new name and symbol on April 16, 2018.
Disclosure documents are available at www.thecse.com
Please note that all open orders will be cancelled at the end of business on April 13, 2018. Dealers are reminded to re-enter their orders.